Abstract
In October 2003, the FDA issued an advisory about the risk for new or increased suicidal thoughts or attempts (but not completed suicides) in children and adolescents taking SSRIs; the advisory was upgraded to a black-box warning in 2005 and extended to young adults in 2007. To learn about long-term changes in depression treatment, a research group that conducted an early analysis on the topic ( Am J Psychiatry 2007; 164:884) has now analyzed managed-care claims data …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
